Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
20/03/2026 06:16
March 20 (Reuters) - Ryvu Therapeutics RVU.WA: REPORTED ON THURSDAY FY NET LOSS AT 101.2 MLN ZLOTYS FY OPERATING REVENUE AT 87.7 MLN ZLOTYS FY OPERATING LOSS 107.6 MLN ZLOTYS Source text for Workspace: nEMBzSCja Further company coverage: RVU.WA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Q1 Net Loss 12.6 Million Zlotys
Brief: Ryvu Therapeutics Updates Romacyclib Development Strategy
Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
Brief: Ryvu Therapeutics Extends Research Collaboration And Exclusive License Agreement With BioNTech Until Nov 29, 2028
Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project